QUAGLIA, Wilma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.698
EU - Europa 7.801
AS - Asia 6.946
SA - Sud America 797
AF - Africa 268
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 47
Totale 32.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.127
CN - Cina 2.811
SG - Singapore 2.066
RU - Federazione Russa 1.807
IT - Italia 1.498
DE - Germania 1.353
BR - Brasile 664
VN - Vietnam 572
HK - Hong Kong 539
GB - Regno Unito 476
UA - Ucraina 473
CA - Canada 465
SE - Svezia 462
FR - Francia 409
FI - Finlandia 401
PL - Polonia 386
TR - Turchia 199
ZA - Sudafrica 185
KR - Corea 177
IN - India 148
IE - Irlanda 130
BD - Bangladesh 91
CZ - Repubblica Ceca 85
JP - Giappone 81
NL - Olanda 73
MX - Messico 69
BE - Belgio 60
AU - Australia 51
AR - Argentina 49
EU - Europa 45
ES - Italia 43
PK - Pakistan 39
IQ - Iraq 36
IR - Iran 36
EG - Egitto 30
EC - Ecuador 24
LT - Lituania 20
AT - Austria 17
RO - Romania 17
HR - Croazia 15
AE - Emirati Arabi Uniti 14
ID - Indonesia 14
MY - Malesia 14
SA - Arabia Saudita 14
MA - Marocco 13
PE - Perù 13
CO - Colombia 12
PH - Filippine 11
UY - Uruguay 11
VE - Venezuela 11
CH - Svizzera 10
DZ - Algeria 10
PT - Portogallo 10
GR - Grecia 9
KE - Kenya 9
TW - Taiwan 9
CL - Cile 8
JM - Giamaica 8
RS - Serbia 8
UZ - Uzbekistan 8
AL - Albania 7
JO - Giordania 7
AZ - Azerbaigian 6
IL - Israele 6
KH - Cambogia 6
NP - Nepal 6
PA - Panama 6
BG - Bulgaria 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KG - Kirghizistan 5
PS - Palestinian Territory 5
TH - Thailandia 5
HU - Ungheria 4
LV - Lettonia 4
PY - Paraguay 4
SN - Senegal 4
TN - Tunisia 4
GA - Gabon 3
IS - Islanda 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
QA - Qatar 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
GH - Ghana 2
GT - Guatemala 2
MT - Malta 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
Totale 32.590
Salva come PNG Salva come JPEG
Città #
Dallas 1.337
Ashburn 1.299
Woodbridge 1.178
Jacksonville 1.137
Singapore 1.110
Fairfield 1.048
Chandler 879
San Jose 764
Ann Arbor 683
Houston 663
Wilmington 604
Hong Kong 527
Boardman 486
Beijing 475
Seattle 442
Nanjing 380
Cambridge 321
Los Angeles 298
Toronto 290
Camerino 273
Dearborn 242
Warsaw 237
New York 232
The Dalles 229
Council Bluffs 203
Ho Chi Minh City 202
Helsinki 192
Düsseldorf 186
San Mateo 178
Seoul 171
Johannesburg 169
Tongling 165
Lawrence 157
Princeton 157
Lauterbourg 150
Columbus 141
Istanbul 141
Nanchang 141
Kraków 138
Moscow 134
Munich 134
Dublin 130
Hanoi 127
Ogden 119
Buffalo 118
Orem 113
Santa Clara 108
London 106
Shanghai 99
Kunming 98
Lachine 92
Milan 90
Shenyang 87
São Paulo 74
Guangzhou 69
Jiaxing 66
Brno 63
Tianjin 63
Tokyo 63
Turku 61
Chicago 58
Brussels 57
Chennai 55
Jinan 55
Hebei 54
Frankfurt am Main 52
Rome 52
Venezia 51
San Diego 50
Changsha 48
Hangzhou 48
Manchester 42
Brooklyn 41
Philadelphia 41
Trieste 41
Poplar 40
Montreal 39
Stockholm 39
Redwood City 37
St Louis 37
Zhengzhou 37
Denver 34
Wuhan 34
Washington 33
Mexico City 31
Nürnberg 31
Ascoli Piceno 30
Da Nang 30
Boston 29
Bremen 29
Phoenix 28
Venice 28
Amsterdam 27
Falls Church 27
Hefei 26
Leawood 26
Ningbo 26
Atlanta 24
Mumbai 24
Nuremberg 24
Totale 21.154
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 645
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 623
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 622
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 560
1'-Benzyl-3,4-dihydrospiro[2H-1-benzothiopyran-2,4'-piperidine] (Spipethiane), a potent and highly selective sigma1 lingand 555
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 339
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 332
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 327
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 323
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 304
Hyperphagic effect of novel compounds with high affinity for imidazoline I2 binding sites 302
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 299
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 290
Nano-medicine improving the bioavailability of small molecules for the prevention of neurodegenerative diseases 273
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 268
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions 268
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 263
2-(2-Phenylcyclopropyl)imidazolines: Reversed Enantioselective Interaction at I1 and I2 Imidazoline Receptors 259
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 254
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 250
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 247
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 241
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 241
alpha(2)-Adrenoreceptors profile modulation. 2. Biphenyline analogues as tools for selective activation of the alpha2C-subtype 237
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 236
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 227
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 226
Discovery of Highly Selective Imidazoline Receptor Ligands 224
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 219
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 218
Imidazoline binding sites (IBS) profile modulation: Key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues 218
Structure-activity relationships in 1,4-benzodioxan-related compounds. Investigation on the role of the dehydrodioxane ring on alpha1-adrenoreceptor blocking activity 218
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 218
Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors 218
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 217
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 216
3-Phenyl analogues of 2-[[[2-(2,6-Dimethoxyphenoxyethyllamino]methyl]-1,4-benzodioxan (WB 4101) as highly selective alpha1-adrenoreceptor antagonists1 212
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 212
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 211
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 209
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 209
Dopamine D-5 receptors: A challenge to medicinal chemists 209
Design, synthesis and muscarinic activity of deoxamuscarine-related derivatives 208
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 207
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 207
Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodide 206
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 205
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 204
Structure-activity relationships among benextramine-related tetraamine disulfides at peripheral alpha-adrenoreceptors 204
Homoazanicotine: A structure-affinity study for nicotinic acetylcholine (nACh) receptor binding 202
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 201
Search for selective antagonists at alpha1-adrenoreceptors: neutral or negative antagonism? 201
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 200
Alpha(2)-Adrenoreceptors Profile Modulation. 3. (R)-(+)-m-Nitrobiphenyline, a New Efficient and alpha(2C)-Subtype Selective Agonist. 198
Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptors 197
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 197
4WD to Travel Inside the 5-HT1A Receptor World 197
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 196
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 195
Antimuscarinic activity in a series of 2-substituted 1,3-dioxolanes 195
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 193
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 193
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 192
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 191
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 190
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders 189
Alpha(2)-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 189
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 189
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 188
Chain-lengthened and imidazoline analogues of nicotine 187
Muscarinic Thioligands with Cyclopentane Nucleus 187
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 186
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 186
Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca2+-activated K+ permeability of erythrocytes 185
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 184
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 183
Synthesis and Structure-Activity Relationship Studies in a Series of 2-Substituted 1,3-Dioxolanes Modified at the Cationic Head. 181
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 181
Synthesis, Absolute Configuration, and Biological Profile of the Enantiomers of trans-[2-(2,6-Dimethoxypheoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (Mephendioxan), a Potent Competitive alpha 1A-Adrenoreceptor Antagonist 180
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 180
Structure-activity relationships in prazosin-related compounds. Effect of replacing a piperazine ring with an alkanediamine moiety on alpha1- adrenoreceptorblocking activity. 180
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 179
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 178
Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4 chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation 178
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 177
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 176
Structure-activity relationships among benextramine-related tetraamine disulfides. Chain length effect on alpha-adrenoreceptor blocking activity1 173
Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors 173
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity 173
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 173
alpha(2)-adrenoreceptors profile modulation. 4. From antagonist, to agonist behavior 172
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 171
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 171
Rational design of novel I1-imidazoline receptor agonists 170
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 169
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 169
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 168
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 167
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 166
Adrenoceptors as targets in drug discovery: Medicinal chemistry and therapeutical potential 166
Totale 23.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 0 0 0 0 0 0 265
2021/20221.729 135 408 28 117 134 88 47 119 134 198 119 202
2022/20232.361 284 70 117 328 268 315 17 137 429 130 170 96
2023/20241.698 221 100 128 57 70 151 74 48 183 68 42 556
2024/20255.664 259 125 462 263 174 323 653 1.338 439 363 380 885
2025/20269.696 547 612 1.678 1.299 972 675 1.344 634 570 639 539 187
Totale 33.058